A Study to Evaluate Vinorelbine Plus Capecitabine Combined With Trastuzumab for HER2 Positive Patients Following Neoadjuvant Chemotherapy

NCT04302441 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

550

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Vinorelbine
DRUG: Capecitabine

Sponsor

Fudan University